Skye Bioscience, Inc. Restricted Cash and Cash Equivalents, Current
Skye Bioscience, Inc. (SKYE) had Restricted Cash and Cash Equivalents, Current of $0 as of 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue · last filed 2025-11-10
- 2025-09-30: Restricted Cash and Cash Equivalents, Current $0.00.
- 2025-06-30: Restricted Cash and Cash Equivalents, Current $0.00.
- 2025-03-31: Restricted Cash and Cash Equivalents, Current $0.00.
- 2024-12-31: Restricted Cash and Cash Equivalents, Current $0.00.
| Period end | Restricted Cash and Cash Equivalents, Current |
|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 |
| 2024-12-31 | $0.00 10-K · filed 2025-03-20 |
| 2024-09-30 | $9.08M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $9.08M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $9.08M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $9.08M 10-K · filed 2025-03-20 |
| 2023-09-30 | $9.08M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $4.59K 10-Q · filed 2024-08-09 |
| 2023-03-31 | $4.59K 10-Q · filed 2024-05-10 |
| 2022-12-31 | $4.58K 10-K · filed 2024-03-22 |
| 2022-09-30 | $4.57K 10-Q · filed 2023-11-14 |
| 2022-06-30 | $4.57K 10-Q · filed 2023-08-07 |
| 2022-03-31 | $4.57K 10-Q · filed 2023-05-12 |
| 2021-12-31 | $4.57K 10-K · filed 2023-03-31 |
| 2021-09-30 | $4.57K 10-Q · filed 2022-11-14 |
| 2021-06-30 | $4.57K 10-Q · filed 2022-08-15 |
| 2021-03-31 | $4.57K 10-Q · filed 2022-05-06 |
| 2020-12-31 | $4.57K 10-K · filed 2022-03-28 |
| 2020-09-30 | $4.54K 10-Q · filed 2021-11-10 |
| 2020-06-30 | $4.54K 10-Q · filed 2021-08-06 |
| 2020-03-31 | $4.54K 10-Q · filed 2021-05-07 |
| 2019-12-31 | $4.54K 10-K · filed 2021-03-02 |
| 2019-09-30 | $4.51K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $4.51K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $4.51K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $4.51K 10-K · filed 2020-03-23 |
| 2018-09-30 | $4.50K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $4.50K 10-Q · filed 2018-08-10 |
| 2018-03-31 | $4.43K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $4.43K 10-K · filed 2019-03-14 |
| 2017-09-30 | $4.43K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $37.50K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $37.50K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $37.50K 10-K · filed 2018-03-19 |
| 2016-09-30 | $37.50K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $37.50K 10-Q · filed 2016-08-12 |
| 2016-03-31 | $37.50K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $37.50K 10-K · filed 2017-03-10 |
| 2015-09-30 | $37.50K 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |